Strs Ohio Biogen Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Biogen Inc. stock. As of the latest transaction made, Strs Ohio holds 49,000 shares of BIIB stock, worth $8.52 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

49,000

Previous 49,000 -0.0%

Holding current value

$8.52 Million

Previous $11.4 Million 16.38%

% of portfolio

0.04%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$190.52 - $236.72 $9.34 Million - $11.6 Million	49,000 New	49,000 $11.4 Million
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $18.1 Million - $21.7 Million	-81,114 Reduced 93.3%	5,825 $1.51 Million
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $11.9 Million - $13.4 Million	-46,977 Reduced 35.08%	86,939 $22.3 Million
Q2 2023 Jul 31, 2023	SELL	$275.25 - $318.06 $780,884 - $902,336	-2,837 Reduced 2.07%	133,916 $38.1 Million
Q1 2023 Aug 02, 2023	BUY	$256.56 - $292.34 $727,860 - $829,368	2,837 Added 2.12%	136,753 $38 Million
Q1 2023 Apr 27, 2023	BUY	$256.56 - $292.34 $52,081 - $59,345	203 Added 0.15%	136,753 $38 Million
Q4 2022 Jan 26, 2023	BUY	$252.44 - $306.72 $34.5 Million - $41.9 Million	136,550 New	136,550 $37.8 Million
Q2 2022 Jul 25, 2022	SELL	$187.54 - $223.02 $8.58 Million - $10.2 Million	-45,733 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $1.05 Million - $1.32 Million	-5,412 Reduced 10.58%	45,733 $9.63 Million
Q4 2021 Jan 24, 2022	SELL	$223.92 - $287.77 $826,712 - $1.06 Million	-3,692 Reduced 6.73%	51,145 $12.3 Million
Q3 2021 Oct 22, 2021	SELL	$282.99 - $369.05 $2.81 Million - $3.66 Million	-9,915 Reduced 15.31%	54,837 $15.5 Million
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $793,317 - $1.27 Million	-3,063 Reduced 4.52%	64,752 $22.4 Million
Q1 2021 Apr 23, 2021	SELL	$242.95 - $284.63 $974,229 - $1.14 Million	-4,010 Reduced 5.58%	67,815 $19 Million
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $2.8 Million - $4.21 Million	-11,838 Reduced 14.15%	71,825 $17.6 Million
Q3 2020 Dec 14, 2020	SELL	$264.77 - $305.71 $1.86 Million - $2.15 Million	-7,041 Reduced 7.76%	83,663 $23.7 Million
Q2 2020 Jul 23, 2020	BUY	$258.66 - $342.55 $696,312 - $922,144	2,692 Added 3.06%	90,704 $24.3 Million
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $3.22 Million - $4.09 Million	11,986 Added 15.77%	88,012 $27.8 Million
Q4 2019 Jan 24, 2020	SELL	$220.06 - $304.07 $1.89 Million - $2.6 Million	-8,567 Reduced 10.13%	76,026 $22.6 Million
Q3 2019 Oct 21, 2019	SELL	$217.44 - $243.88 $2.38 Million - $2.67 Million	-10,946 Reduced 11.46%	84,593 $19.7 Million
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $1.53 Million - $1.69 Million	-6,983 Reduced 6.81%	95,539 $22.3 Million
Q1 2019 Apr 19, 2019	SELL	$216.71 - $338.96 $3.59 Million - $5.61 Million	-16,553 Reduced 13.9%	102,522 $24.2 Million
Q4 2018 Jan 23, 2019	BUY	$278.5 - $352.75 $235,054 - $297,721	844 Added 0.71%	119,075 $35.8 Million
Q3 2018 Oct 19, 2018	SELL	$293.51 - $383.83 $4 Million - $5.24 Million	-13,644 Reduced 10.35%	118,231 $41.8 Million
Q2 2018 Aug 06, 2018	SELL	$257.52 - $306.91 $20.1 Million - $24 Million	-78,102 Reduced 37.2%	131,875 $38.3 Million
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $17.5 Million - $24.7 Million	-67,155 Reduced 24.23%	209,977 $57.5 Million
Q4 2017 Jan 23, 2018	SELL	$307.64 - $344.58 $5.67 Million - $6.35 Million	-18,436 Reduced 6.24%	277,132 $88.3 Million
Q3 2017 Oct 23, 2017	BUY	$281.15 - $329.69 $83.1 Million - $97.4 Million	295,568	295,568 $92.5 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account